Feb 02, 2021: The global next generation sequencing market is anticipated to reach USD 21.4 billion by 2025. NGS market is expected to show a tremendous growth on account of its wide applications in the treatment of cancer. NGS is the process of identifying accurate order of nucleotides within a RNA or a DNA molecule. Advancement of NGS has helped biological and medical discovery and research. It has helped in various applied fields which includes biotechnology, forensic research, virology and medical diagnosis. NGS has made possible sequencing of DNA of various species including the human genome.
Introduction of advanced genetic sequencing and development of advance techniques for whole genomes are the major drivers contributing to the overall market growth. Increasing incidences of cancer and infectious diseases coupled with aging population is expected to fuel the demand for these technologies. Further, the overall cost of genome sequencing is expected to reduce drastically on account of rapid development through research and innovation. High capacity genome sequencing has been contributing significantly towards the market growth.
Download sample Copy of This Report at: https://www.millioninsights.com/industry-reports/next-generation-sequencing-ngs-market/request-sample
NGS has wide applications in the field of exome and genome sequencing. They are widely used in the treatment of infectious disease and cancer. NGS has shown a key presence in pathogen analysis which has been helpful in the treatment of infectious diseases. The need for effective diagnosis for cancer and high growing usage of combinational biomarkers are other factors contributing to the growth of the market in recent years.
NGS has been mostly a topic of research and development in the previous decade. At present they find applications in the field of oncology, prenatal testing, HLA testing, idiopathic diseases, and medical research. Research and development in the field of HLA and prenatal testing have provided new avenues to doctors in gaining insights during organ matching and organ rejection.
The development in the treatment of genetic anomalies and diseases with the help of prenatal genome sequencing has been driving the NGS market. This technology has also helped the pharmaceutical companies in developing essential drugs for the treatment of cancer and infectious diseases. Growing concerns and increasing incidences of cancer is expected to be the major driving factor for the development of NGS.
Read Complete Report With TOC @ https://www.millioninsights.com/industry-reports/next-generation-sequencing-ngs-market
NGS in the field of organ transplant provides great opportunities over the forecast period. It is important that the characteristics of both the donors and the acceptors match for a successful transplant. NGS helps in studying the immune response to the transplanted organ. Medical tourism development in countries including the U.S, Israel, Singapore and Australia provide bright prospects for overall growth of the market.
Next generation sequencing market is segmented as target, genome, exon and resequencing. The largest share is held by target sequencing followed by genome sequencing. Development of whole genome sequencing capabilities is expected to show a significant growth over the forecast period. Whole genome technology is relatively new and is gaining popularity with the development of high throughput. This high throughput has helped in reducing complications associated with whole genome sequencing.
NGS includes sample enrichment, DNA tagging, library preparation, sample quality assurance, DNA quantification, data storage, genetic data assembly, analysis and interpretation. With the increase in volume of whole genome sequencing, next generation data analysis is expected to observe a significant growth over the forecast period.
Government regulatory bodies play a vital role in overall development and usage of these technologies. Medical device manufacturers in the U.S. are under the strict vigilance of Food and Drug Administration (FDA). In 2013, FDA approved four next generation gene sequencing devices which is expected to help physicians in taking a broader look at the patient’s genetic makeup. Two of the approved devices is expected to help in detecting DNA changes in the treatment of cystic fibrosis.
Get in touch
At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.
Contact Person:
Ryan Manuel
Research Support Specialist, USA
Email: [email protected]
Global Headquarters
Million Insights
Felton Office Plaza 6265 Highway 9 Felton, California 95018, United States
Phone: 1-408-610-2300
Email: [email protected]
Asia Pacific
Million Insights
Office No. 302, 3rd Floor, Manikchand Galleria, Model Colony, Shivaji Nagar, Pune, MH, 411016 India
Phone: 91-20-65300184
Next Generation Sequencing Market is anticipated to reach USD 21.4 billion by 2025.
NGS market is expected to show a tremendous growth on account of its wide applications in the treatment of cancer.
NGS is the process of identifying accurate order of nucleotides within a RNA or a DNA molecule.
Advancement of NGS has helped biological and medical discovery and research.
Further, the overall cost of genome sequencing is expected to reduce drastically on account of rapid development through research and innovation.
The need for effective diagnosis for cancer and high growing usage of combinational biomarkers are other factors contributing to the growth of the market in recent years.
The global next generation sequencing market is anticipated to reach USD 21.4 billion by 2025.
NGS market is expected to show a tremendous growth on account of its wide applications in the treatment of cancer.
NGS is the process of identifying accurate order of nucleotides within a RNA or a DNA molecule.
Advancement of NGS has helped biological and medical discovery and research.
Further, the overall cost of genome sequencing is expected to reduce drastically on account of rapid development through research and innovation.
At present they find applications in the field of oncology, prenatal testing, HLA testing, idiopathic diseases, and medical research.
The global Next Generation Sequencing Market is anticipated to reach USD 21.4 billion by 2025.
NGS market is expected to show a tremendous growth on account of its wide applications in the treatment of cancer.
NGS is the process of identifying accurate order of nucleotides within a RNA or a DNA molecule.
Advancement of NGS has helped biological and medical discovery and research.
Further, the overall cost of genome sequencing is expected to reduce drastically on account of rapid development through research and innovation.
At present they find applications in the field of oncology, prenatal testing, HLA testing, idiopathic diseases, and medical research.
The growing demand for big data analysis includes increase in easy sharing, mobile devices, internet penetration, abundant information and resources.
At present due to cloud computing there is elevating demand for storage space and in coming nine years it is expected to witness more healthy growth.Software InsightsVisualization or Graphical user interface (GUI) is important because user need to access data when required.
The big data market is expected to present great opportunity for data vendor in next four to five years, so proper and effective visualization is needed.Big data analytics is processing large data sets to discover correlations, market trends and hidden patterns which is handy in making business decisions.
This segment is also expected to grow due to increase in awareness of analytics in large enterprises for making strategic decisions and to reduce risk of failure.Service InsightsService is delivery of information, consulting or statistical analysis tools to a firm by outside provider that helps to understand and use large information.
Demand for technicians and vendor executive will witness growth over forecasted period.End-Use InsightsDeveloped economics used data intensive technology on large scale.
Companies invest heavily for effective data traffic management tools such as predictive text analysis.
13 February 2020 - Global Facial Injectables Market is expected to reach USD 17.2 billion by 2025.
Facial injectable is also termed as facial filler, or facial injections, or injectable fillers are the products like calcium hydroxylapatite, collagen, and hyaluronic acid that revitalize facial skin by reducing and eradicating wrinkles, enhancing lips, raising scar depressions, and altering soft-tissue volume loss through facial injections.
Probably the results are temporary that lasts from few months to years.
The Facial Injectable Market is estimated to grow at a significant CAGR of 11.5% over the forecast period as the scope and its applications are rising enormously across the globe.Growing demand from middle age populace, growing urbanization, and increasing esthetic standards are documented as major factors of Facial Injectables Market that are estimated to enhance the growth in the years to come.
However, its side effects and high cost may restrain overall market growth in the coming years.
Facial Injectables industry is segmented based on product type, end user, and region.Request a Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/facial-injectables-marketAnti-aging/ Anti-wrinkle Injections and Dermal Fillers/Injectable Implants are the product types that could be explored in Facial Injectables in the forecast period.
Mar 04, 2021: The global Polymethyl Methacrylate (PMMA) Market is expected to gain a significant CAGR during the forecast period.
Polymethyl Methacrylate, often termed as PMMA, is a commonly used thermoplastic polymer in daily life.
PMMA is the most commercially used acrylic polymer and is available under various brand names.
PMMA is a widely preferred replacement for glass since it is highly transparent that is more vulnerable to serious impact.
PMMA is much compatible to the human tissue that makes it important in the field of prosthetics and ophthalmology due to its transparent properties.Chemically, PMMA is formed due to emulsion or polymerization of methacrylic acid.
PMMA is used across various industries due to its features comprising high thermal & chemical resistance, abrasion resistance, and low smoke emission.By product, the PMMA market segmentation comprises extruded sheets, acrylic beads, and pellets.
